GOP Questions Smithfield Deal's Effect On Heparin Supply

Law360, New York (July 25, 2013, 4:51 PM ET) -- U.S. House Republicans expressed concern Wednesday that a Chinese pork producer's $7.1 billion acquisition of Smithfield Foods Inc. could jeopardize the U.S. supply of heparin, the blood-thinning drug linked to a 2008 contamination episode that killed more than 80 people.

Lawmakers have previously warned that Shuanghui International Holdings Ltd.'s pending purchase of Smithfield raises food safety concerns, but the top Republicans on the House Energy and Commerce Committee said in a letter to Smithfield CEO Larry Pope that they believed the transaction could threaten the safety...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required